您好!欢迎来到化工e站网 登录 注册
我的EWeb ▼
导航菜单 ▼
中文 ▼
医药中间体
无机化工
有机原料
原料药
染料及颜料
表面活性剂
香精与香料
化学试剂
食品添加剂
催化剂及助剂
分析化学
首页 化工产品目录 盐酸恩诺沙星
93106-59-3
盐酸恩诺沙星
产品纠错
CAS号:93106-59-3 | 英文名称:ENROFLOXAIN HYDROCHLORIDE
分子式
分子量
EINECS号
MDL
Smiles
InChIKey
盐酸恩诺沙星化学百科
基本信息
中文名称 盐酸恩诺沙星
英文名称 ENROFLOXAIN HYDROCHLORIDE
CAS号 93106-59-3
分子式 C19H23ClFN3O3
分子量 395.8556232
EINECS号 274-614-4
物化性质
形态 固体
颜色 白色至米白色
水溶解性 Water : 7.14 mg/mL (Need ultrasonic)
安全信息
生产及用途
Enrofloxacin monohydrochloride (BAY Vp 2674 monohydrochloride) 是一种有效的抗生素,作用于 Mycoplasma bovis,MIC90 为 0.312 μg/ mL。

MIC90: 0.312 μg/mL ( Mycoplasma bovis )

Mycoplasma bovis is a worldwide pathogen, causative agent of pneumonia, mastitis, arthritis, and a variety of other symptoms in cattle. The antibiotic susceptibility profiles of the Hungarian strains are consistent within the tested group of fluoroquinolones. Three isolates (MYC44, MYC45 and MYC46) have high MIC values (≥10 μg/mL) to Enrofloxacin, while the rest of the strains are inhibited by Enrofloxacin with MICs ≤0.312 or 0.625 μg/mL.

Mice (n=80) undergo transient middle cerebral artery occlusion (MCAo) with reperfusion after 60 minutes. After MCAo, animals are randomly assigned to receive either a daily preventive medication (n=26, Enrofloxacin) starting at the day of MCAo or a therapeutic medication (n=25; Enrofloxacin) after diagnosis of lung infection. Standard treatment started immediately after the appearance of clinical signs (general health score>6) usually between day 4 and 6 after stroke. Both, preventive and standard antibiotic treatment using Enrofloxacin improve survival in a similar way compared with placebo treatment.

上下游产品
上游产品共计:0个
下游产品共计:0个
相关产品
产品供应商